Cognex (NASDAQ:CGNX) Stock, Quote.Headers.trade-ideas

Cognex

Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's own cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.

Energy Considerations

Long Ideas

News

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

CGNX

LULU

TALO

Over $40M Bet On PBF Energy? Check Out These 4 Stocks Executives Are Buying

wall street chart shutter2

Earnings

Price Target

Analyst Ratings

These Analysts Cut Their Forecasts On Cognex Following Q2 Results

Image 6

ARGX

CHTR

DAIO

LGVN

MPWR

SCHW

TXRH

Northrop Grumman To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday

Cognex Corp

<p>Although U.S. stocks closed mixed on Thursday, there were a few notable insider trades.</p>
<p>When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.</p>
<p>Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.</p>
<h3 class="wp-block-heading"><strong>PBF Energy</strong></h3>
<ul>
<li><strong>The Trade: PBF Energy Inc. </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBF#NYSE">PBF</a>) 10% owner Control Empresarial de Capitales S.A. de C.V.<a href="https://www.benzinga.com/quote/PBF/analyst-ratings"> acquired a total of 1,210,000 shares at</a> an average price of $33.25. To acquire these shares, it cost around $40.2 million.</li>
<li><strong>What's Happening:</strong> PBF Energy will release its earnings results for the third quarter 2024 on Thursday, Oct. 31.</li>
<li><strong>What PBF Energy Does:</strong> PBF Energy Inc is an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States.</li>
</ul>
<h3 class="wp-block-heading"><strong>Talos Energy</strong></h3>
<ul>
<li><strong>The Trade:</strong> <strong>Talos Energy Inc. </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TALO#NYSE">TALO</a>) 10% owner Control Empresarial de Capitales S.A. de C.V. acquired a total of 2,397,000 shares at an average price of $11.08. To acquire these shares, it cost around $26.5 million.</li>
<li><strong>What's Happening:</strong> The company disclosed that its Ewing Bank 953 well has successfully discovered commercial quantities of oil and natural gas.</li>
<li><strong>What Talos Energy Does:</strong> Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production.</li>
</ul>
<h3 class="wp-block-heading"><strong>Cognex</strong></h3>
<ul>
<li><strong>The Trade:</strong> <strong>Cognex Corporation </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) SVP, Chief Financial Officer Dennis Fehr <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 6,570 shares</a> at an average price of $38.04. To acquire these shares, it cost around $249,920.</li>
<li><strong>What's Happening:</strong> On July 31, Cognex reported mixed second-quarter financial results.</li>
<li><strong>What Cognex Does:</strong> Cognex Corp provides machine vision products that help automate manufacturing processes.</li>
</ul>
<h3 class="wp-block-heading"><strong>Lululemon Athletica</strong></h3>
<ul>
<li><strong>The Trade:</strong> <strong>Lululemon Athletica Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) CEO Calvin McDonald <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 4,000 shares</a> at an average price of $260.00. The insider spent around $1.04 million to buy those shares.</li>
<li><strong>What's Happening:</strong> On Aug. 29, Lululemon Athletica reported better-than-expected second-quarter EPS results.</li>
<li><strong>What Lululemon Athletica Does:</strong> Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls.</li>
</ul>
<p><strong>Check This Out:<a href="https://www.benzinga.com/top-stories/24/09/40730015/jim-cramer-oklo-is-losing-money-hand-over-fist-but-this-private-equity-stock-is-a-buy"> </a></strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/top-stories/24/09/40730015/jim-cramer-oklo-is-losing-money-hand-over-fist-but-this-private-equity-stock-is-a-buy">Jim Cramer: Oklo Is Losing Money &#8216;Hand-Over-Fist,&#8217; But This Private Equity Stock Is A Buy</a></strong></li>
</ul>


WIIM

AAPL

AEIS

AEVA

ANET

ASNS

BBAI

COHR

Core Scientific, Inc. - Class A Common Stock

CORZ

CRSR

DAKT

DELL

DOCN

DTST

EGIO

EVLV

FIVN

FLEX

GDDY

GTLB

KEYS

KOPN

LITE

LWLG

NSIT

PLUS

PSTG

SHOP

SNOW

VECO

ZBRA

Shares of companies within the broader tech sector are trading lower amid overall market weakness. Weakness may be due to August's ISM Manufacturing PMI data indicating an economic contraction.

<p>DA Davidson  analyst Matthew Summerville   maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Neutral and lowers the price target from $41 to $39.</p>


DA Davidson Maintains Neutral on Cognex, Lowers Price Target to $39

<p>Stephens &amp; Co.  analyst Tommy Moll   reiterates Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Equal-Weight and maintains $45 price target.</p>


Reiteration

Stephens & Co. Reiterates Equal-Weight on Cognex, Maintains $45 Price Target

ADBE

ALGM

APLD

AVGO

BILL

BRZE

CDNS

COMM

CSCO

DDOG

DOCU

ERIC

ESTC

FSLR

GOOG

GOOGL

INFY

INTC

INTU

IREN

MRVL

MSFT

NTAP

NTNX

NVDA

OKTA

ORCL

OUST

PANW

PCOR

PLTR

QRVO

SMCI

SMTC

SWKS

TOYO

TRMB

TWLO

VSAT

WDAY

ZETA

Shares of stocks in the broader tech sector are trading lower as stocks sell off amid concerns over the US economy.

<p>Baird  analyst Richard Eastman   maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Neutral and lowers the price target from $46 to $42.</p>


Baird Maintains Neutral on Cognex, Lowers Price Target to $42

<p>Goldman Sachs  analyst Joe Ritchie   maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Sell and lowers the price target from $45 to $39.</p>


Goldman Sachs Maintains Sell on Cognex, Lowers Price Target to $39

<p><strong>Cognex Corporation</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) reported mixed second-quarter financial results, after the<a href="https://www.benzinga.com/quote/CGNX"> closing bell on Wednesday</a>.</p>
<p>Cognex reported quarterly earnings of 23 cents per share which beat the analyst consensus estimate of 21 cents per share. The company reported quarterly sales of $239.00 million which missed the analyst consensus estimate of $240.39 million.</p>
<p>&#8220;Cognex delivered second quarter revenue and gross margin in line with expectations and operating expenses favorable to our guidance,&#8221; said Robert J. Willett, CEO. &#8220;Year-on-year revenue growth in the quarter was strong in our Logistics and Semiconductor end markets, however revenue across the rest of our factory automation business continues to be soft.&#8221;</p>
<p>Cognex shares fell 21.2% to close at $39.08 on Thursday.</p>
<p>These analysts made changes to their price targets on Cognex following earnings announcement.</p>
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/591b27b4290fa70001b1563e/james-ricchiuti">Needham analyst James Ricchiuti </a>maintained Cognex with a Buy and lowered the price target from $57 to $50.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58ac4af1b85e930001e6383a/jamie-cook">Truist Securities analyst Jamie Cook </a>maintained Cognex with a Buy and lowered the price target from $55 to $46.</li>
</ul>
<p>R<strong>ead More: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/news/earnings/24/08/40122820/amazon-apple-and-3-stocks-to-watch-heading-into-friday">Amazon, Apple And 3 Stocks To Watch Heading Into Friday</a></strong></li>
</ul>


<p>Truist Securities  analyst Jamie Cook   maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Buy and lowers the price target from $55 to $46.</p>


Truist Securities Maintains Buy on Cognex, Lowers Price Target to $46

<p>Needham  analyst James Ricchiuti   maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Buy and lowers the price target from $57 to $50.</p>


Needham Maintains Buy on Cognex, Lowers Price Target to $50

Cognex shares are trading lower after the company reported mixed Q2 financial results.

Guidance

Cognex Expects Q3 Revenue of $225M-$240M, Slight Sequential Decrease From Q2 But Slight YoY Increase Excluding Moritex; Moritex To Contribute 10%-12% of Q3 Revenue; Adjusted Gross Margin Slightly Below 70%; Adjusted EBITDA Margin 16%-19%; Adjusted Effective Tax Rate 16%

<p>Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.21 by 9.52 percent.  The company reported quarterly sales of $239.00 million which missed the analyst consensus estimate of $240.39 million by 0.58 percent.  This is a 1.45 percent decrease over sales of $242.51 million the same period last year.</p>


Earnings Beats

Earnings Misses

Cognex Q2 2024 Adj EPS $0.23 Beats $0.21 Estimate, Sales $239.00M Miss $240.39M Estimate

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-ratings/">analyst ratings page</a>.</p>
<ul>
<li>Deutsche Bank increased <strong>Northrop Grumman Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) price target from $474 to $575. Deutsche Bank analyst Scott Deuschle upgraded the stock from Hold to Buy. Northrop Grumman shares gained 2.1% to close at $480.30 on Friday. <a href="https://www.benzinga.com/quote/NOC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler cut the price target for <strong>The Charles Schwab Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) from $80 to $64. Piper Sandler analyst Patrick Moley downgraded the stock from Overweight to Neutral. Charles Schwab shares gained 0.5% to close at $66.60 on Friday. <a href="https://www.benzinga.com/quote/SCHW/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Pivotal Research boosted the price target for <strong>Charter Communications, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) from $400 to $435. Pivotal Research analyst Jeffrey Wlodarczak maintained a Buy rating. Charter Communications shares gained 16.6% to close at $367.62 on Friday. <a href="https://www.benzinga.com/quote/CHTR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stephens &amp; Co. boosted the price target for <strong>Texas Roadhouse, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXRH#NASDAQ">TXRH</a>) from $170 to $176. Stephens &amp; Co. analyst Jim Salera maintained an Equal-Weight rating. Texas Roadhouse shares rose 2% to close at $169.38 on Friday. <a href="https://www.benzinga.com/quote/TXRH/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham boosted <strong>Cognex Corporation</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) price target from $48 to $57. Needham analyst James Ricchiuti maintained a Buy rating. Cognex shares rose 2% to close at $49.68 on Friday. <a href="https://www.benzinga.com/quote/CGNX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. cut the price target for <strong>Longeveron Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) from $12 to $10. HC Wainwright &amp; Co. analyst Raghuram Selvaraju maintained a Buy rating. Longeveron shares rose 13.2% to close at $3.44 on Friday. <a href="https://www.benzinga.com/quote/LGVN/analyst-ratings">See how other analysts view this stock.</a></li>
<li>WestPark Capital cut <strong>Data I/O Corporation</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAIO#NASDAQ">DAIO</a>) price target from $5 to $4. WestPark Capital analyst Kevin Garrigan maintained a Buy rating. Data I/O shares fell 4.3% to close at $2.67 on Friday. <a href="https://www.benzinga.com/quote/DAIO/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Keybanc boosted <strong>The Trade Desk, Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) price target from $100 to $105. Keybanc analyst Justin Patterson maintained an Overweight rating. Trade Desk shares rose 1.7% to close at $92.43 on Friday. <a href="https://www.benzinga.com/quote/TTD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird raised <strong>argenx SE</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NASDAQ">ARGX</a>) price target from $490 to $515. Baird analyst Joel Beatty maintained an Outperform rating. argenx shares gained 1.7% to close at $494.46 on Friday. <a href="https://www.benzinga.com/quote/ARGX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Rosenblatt boosted <strong>Monolithic Power Systems, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPWR#NASDAQ">MPWR</a>) price target from $800 to $880. Rosenblatt analyst Hans Mosesmann maintained a Buy rating. Monolithic Power shares rose 4% to close at $821.78 on Friday. <a href="https://www.benzinga.com/quote/MPWR/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
<p><strong>Check This Out: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/40007546/anixa-biosciences-and-3-other-stocks-under-5-insiders-are-buying">Anixa Biosciences And 3 Other Stocks Under $5 Insiders Are Buying</a></strong></li>
</ul>


<p>Needham  analyst James Ricchiuti   maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Buy and raises the price target from $48 to $57.</p>


Needham Maintains Buy on Cognex, Raises Price Target to $57

<p>In the latest quarter, 9 analysts provided ratings for Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>), showcasing a mix of bullish and bearish perspectives.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $49.78, a high estimate of $58.00, and a low estimate of $41.00. Surpassing the previous average price target of $44.43, the current average has increased by 12.04%.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1721750524_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>In examining recent analyst actions, we gain insights into how financial experts perceive Cognex. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kevin McCarthy</td>
<td>Vertical Research</td>
<td>Announces</td>
<td>Buy</td>
<td>$58.00</td>
<td>-</td>
</tr>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$55.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Helen Fang</td>
<td>HSBC</td>
<td>Announces</td>
<td>Buy</td>
<td>$52.00</td>
<td>-</td>
</tr>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$50.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Joe Ritchie</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Sell</td>
<td>$41.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Tommy Moll</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$45.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Jay Huang</td>
<td>Bernstein</td>
<td>Raises</td>
<td>Outperform</td>
<td>$55.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>James Ricchiuti</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$48.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Richard Eastman</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$44.00</td>
<td>$40.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Cognex. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Cognex compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Cognex's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>For valuable insights into Cognex's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CGNX/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Cognex analyst ratings.</strong></a></p>
<h2>Get to Know Cognex Better</h2>
<p>Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's own cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.</p>
<h3>A Deep Dive into Cognex's Financials</h3>
<p><strong>Market Capitalization Highlights:</strong> Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.</p>
<p><strong>Revenue Growth:</strong> Cognex's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2024, the company achieved a revenue growth rate of approximately <strong>4.81%</strong>. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Cognex's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>5.7%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>0.8%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Cognex's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>0.6%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.05</strong>.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Where Cognex Stands With Analysts

<p>Vertical Research  analyst Kevin McCarthy   initiates coverage on Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Buy rating and announces Price Target of $58.</p>


Initiation

Vertical Research Initiates Coverage On Cognex with Buy Rating, Announces Price Target of $58

<p>9 analysts have expressed a variety of opinions on Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $48.11, a high estimate of $55.00, and a low estimate of $41.00. This current average reflects an increase of 9.34% from the previous average price target of $44.00. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1719928866_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>In examining recent analyst actions, we gain insights into how financial experts perceive Cognex. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$55.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Helen Fang</td>
<td>HSBC</td>
<td>Announces</td>
<td>Buy</td>
<td>$52.00</td>
<td>-</td>
</tr>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$50.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Joe Ritchie</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Sell</td>
<td>$41.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Tommy Moll</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$45.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Jay Huang</td>
<td>Bernstein</td>
<td>Raises</td>
<td>Outperform</td>
<td>$55.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>James Ricchiuti</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$48.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Richard Eastman</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$44.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Piyush Avasthy</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$43.00</td>
<td>$41.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Cognex. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Cognex compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of Cognex's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Capture valuable insights into Cognex's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CGNX/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Cognex analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind Cognex</h2>
<p>Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's own cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.</p>
<h3>Cognex's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Cognex showcased positive performance, achieving a revenue growth rate of <strong>4.81%</strong> as of 31 March, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>5.7%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Cognex's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>0.8%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Cognex's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>0.6%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Cognex's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.05</strong>.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Expectations For Cognex's Future

<p>Truist Securities  analyst Jamie Cook   maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Buy and raises the price target from $50 to $55.</p>


Truist Securities Maintains Buy on Cognex, Raises Price Target to $55

Goldman Sachs analyst Joe Ritchie maintained a Sell rating on Cognex (CGNX – Research Report) today and set a price target of $39.00. Joe Ritchie h...

Cognex Corporation: Sell Rating Justified by Diminished Financial Outlook and Underperforming Initiatives

LRT Capital Management July 2024 Investor Update

Cognex: Waiting For The Right Entry Point

Dividend Champion, Contender, And Challenger Highlights: Week Of August 11

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Now could be a great time for investors to consider the best robotics stocks to buy in August. I wrote around a month ago that there could be record <a href="https://investorplace.com/2024/08/qualcomm-stock-analysis-is-qcom-a-buy-sell-or-hold-right-now/">volatility</a> in the market. That prediction turned out to be true, and volatility has since been decreasing. Decreased volatility generally leads to decreased fear and higher stock prices. Buying these best robotics stocks now could be a great option for investors to take advantage of short-term swings in the market.</p>



<p>Also, as the market expands, with projections estimating a <a href="https://www.marketresearchfuture.com/reports/robotics-market-4732">growth</a> to over $286 billion by 2032, investors are keen to identify companies that will benefit most from these advancements. Many of the best robotics stocks on this list are currently undervalued and could have substantial upside ahead for investors.</p>



<p>So here are three companies for investors to consider.</p>



<h2>iRobot (IRBT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/07/irbt1600-300x169.png" alt="In this photo illustration the iRobot Corporation (IRBT) logo seen displayed on a smartphone screen"><div>Source: rafapress / Shutterstock.com</div></div><p><strong>iRobot</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/irbt-stock-quote/"><strong>IRBT</strong></a>) is famous for the Roomba vacuum cleaner and currently trades at a new low. There are substantial risks to investing in IRBT, but I feel that it is currently undervalued. Most of the risks come from the significant <a href="https://investor.irobot.com/news-releases/news-release-details/irobot-reports-second-quarter-2024-financial-results">losses</a> it has accumulated, including a $61.1 loss per share last quarter.</p>



<p>However, I am optimistic that IRBT stock can turn its fortunes around. The company has aggressively restructured its operations. This restructuring has also led to significant cost savings, including a 41% reduction in inventory year-over-year, and a narrowed operating loss in Q2 2024 compared with the previous corresponding period.</p>



<p>These measures are expected to improve its EPS <a href="https://stockanalysis.com/stocks/irbt/forecast/">substantially</a> over the next two years, with EPS rising to a negative $1.20 by FY2026. The stock is certainly risky, but there is potential upside for investors as it trades at just 0.29x sales.</p>



<h2>Cognex Corporation (CGNX)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/02/cognex-cgnx-stock-phone-1600-300x169.jpg" alt="Cognex (CGNX) logo displayed on smartphone with pink and blue background behind, symbolizing CGNX stock"><div>Source: shutterstock.com/rafapress</div></div><p><strong>Cognex Corporation</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/cgnx-stock-quote/"><strong>CGNX</strong></a>) provides automation systems that aid in the processes of manufacturing and distribution. Effectively, its tech allows machines to capture and analyze visual information, which is crucial for high-tech manufacturing.</p>



<p>In Q2 2024, Cognex <a href="https://s2.q4cdn.com/773500753/files/doc_earnings/2024/q2/earnings-result/cognex-press-release-q2-24.pdf">generated</a> $239 million in revenue, down 1% YOY but up 14% sequentially from Q1 2024. Despite softness in its factory automation business, Cognex saw robust growth in its Logistics and Semiconductor markets.&nbsp;</p>



<p>It should be noted that various robotics and automation stocks have been pressured due to inflation, interest rates, geopolitical instability and being at a lower point in the business cycle. I believe then that investors should consider CGNX as a potential investment. For Q3 2024, Cognex expects revenue between $225 million and $240 million, with a slight decrease from Q2 2024 due to seasonal factors. However, its long-term view looks accretive due to automation likely playing a key role in manufacturing.</p>



<h2>Intuitive Surgical (ISRG)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/02/isrg-stock-300x169.jpg" alt="A sign with the Intuitive Surgical logo standing outside of a company office. ISRG stock."><div>Source: Sundry Photography / Shutterstock.com</div></div><p>I have been very bullish on the potential of <strong>Intuitive Surgical </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/isrg-stock-quote/"><strong>ISRG</strong></a>) to maintain its market share whilst simultaneously growing its revenue and earnings over time. The company has an established <a href="https://www.ibisworld.com/us/company/intuitive-surgical-inc/406208/#:~:text=In%20the%20US%2C%20the%20company%20has%20a,and%20revenue%20growth%20compared%20to%20their%20peers.">foothold</a> in the robotics surgery market. It currently holds the largest market share for the robotic surgery market at the time of writing.</p>



<p>The high switching costs of changing machines and manufacturers provide ISRG stock with a natural protective moat that will sustain its earnings and cash flow. The average <a href="https://www.medtechdive.com/news/intuitive-da-vinci-5-robot-launch-plan/710547/">outlay</a> for one of ISRG&rsquo;s machines starts at around $1.42 million, with additional training and maintenance fees included to be on top of that price. ISRG&rsquo;s machines feature prominently in hospitals and it is working on developing more advanced robotics solutions in the future, such as with its Da Vinci 5 model.</p>



<p>I think that ISRG trades at a discount to its fair value given that it has momentum on its side, with its stock price increasing 41.77% year-to-date.&nbsp;<br></p>



<p><em>On the date of publication, Matthew Farley did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed are those of the writer, subject to the</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/"><em> </em>InvestorPlace.com Publishing Guidelines</a>.</p>



<p><em>On the date of publication, the responsible editor did not have (either directly or<br>indirectly) any positions in the securities mentioned in this article.</em></p>
<div><p>Matthew started writing coverage of the financial markets during the crypto boom of 2017 and was also a team member of several fintech startups. He then started writing about Australian and U.S. equities for various publications. His work has appeared in MarketBeat, FXStreet, Cryptoslate, Seeking Alpha, and the New Scientist magazine, among others.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>
<p>The post <a href="https://investorplace.com/2024/08/the-3-best-robotics-stocks-to-buy-in-august-2024/">The 3 Best Robotics Stocks to Buy in August 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Cognex

Cognex (CGNX) Forecast

Cognex (NASDAQ:CGNX) Stock, Quote.Headers.trade-ideas